Lindbrook Capital LLC Has $402,000 Position in KKR & Co. Inc. (NYSE:KKR)

Lindbrook Capital LLC boosted its holdings in KKR & Co. Inc. (NYSE:KKR) by 94.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,077 shares of the asset manager’s stock after acquiring an additional 1,491 shares during the quarter. Lindbrook Capital LLC’s holdings in KKR & Co. Inc. were worth $402,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Washington Trust Advisors Inc. lifted its position in shares of KKR & Co. Inc. by 13.4% during the 3rd quarter. Washington Trust Advisors Inc. now owns 768 shares of the asset manager’s stock worth $100,000 after buying an additional 91 shares during the period. SpiderRock Advisors LLC acquired a new stake in shares of KKR & Co. Inc. in the 3rd quarter valued at $3,319,000. CWA Asset Management Group LLC bought a new stake in shares of KKR & Co. Inc. in the 3rd quarter worth about $1,812,000. Hollencrest Capital Management increased its position in shares of KKR & Co. Inc. by 53.8% during the 3rd quarter. Hollencrest Capital Management now owns 1,830 shares of the asset manager’s stock worth $239,000 after purchasing an additional 640 shares in the last quarter. Finally, TFB Advisors LLC lifted its holdings in KKR & Co. Inc. by 16.3% during the 3rd quarter. TFB Advisors LLC now owns 5,856 shares of the asset manager’s stock valued at $765,000 after purchasing an additional 821 shares during the last quarter. Institutional investors and hedge funds own 76.26% of the company’s stock.

Analysts Set New Price Targets

Several analysts have weighed in on the stock. Barclays upped their price objective on shares of KKR & Co. Inc. from $149.00 to $166.00 and gave the stock an “overweight” rating in a research note on Friday, October 25th. Keefe, Bruyette & Woods reaffirmed an “outperform” rating and set a $144.00 price target (up from $125.00) on shares of KKR & Co. Inc. in a report on Thursday, August 1st. TD Cowen lifted their price objective on KKR & Co. Inc. from $166.00 to $184.00 and gave the company a “buy” rating in a research report on Friday, October 25th. Evercore ISI increased their target price on KKR & Co. Inc. from $135.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Finally, Wells Fargo & Company lifted their price target on KKR & Co. Inc. from $139.00 to $152.00 and gave the company an “equal weight” rating in a report on Friday, October 25th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $151.64.

Insider Activity

In related news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the completion of the transaction, the insider now owns 25,260,971 shares in the company, valued at approximately $650,470,003.25. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other KKR & Co. Inc. news, major shareholder Kkr Group Partnership L.P. acquired 11,619,998 shares of the firm’s stock in a transaction that occurred on Wednesday, September 11th. The stock was acquired at an average cost of $11.13 per share, for a total transaction of $129,330,577.74. Following the transaction, the insider now owns 92,959,984 shares of the company’s stock, valued at $1,034,644,621.92. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the sale, the insider now directly owns 25,260,971 shares of the company’s stock, valued at approximately $650,470,003.25. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 39.34% of the stock is currently owned by company insiders.

KKR & Co. Inc. Trading Up 1.0 %

Shares of NYSE KKR opened at $152.20 on Friday. KKR & Co. Inc. has a fifty-two week low of $62.24 and a fifty-two week high of $153.51. The firm has a market capitalization of $135.19 billion, a P/E ratio of 46.26, a P/E/G ratio of 1.23 and a beta of 1.61. The company has a debt-to-equity ratio of 0.82, a current ratio of 0.07 and a quick ratio of 0.07. The company’s 50 day simple moving average is $132.81 and its 200 day simple moving average is $117.21.

KKR & Co. Inc. (NYSE:KKR) last posted its quarterly earnings results on Thursday, October 24th. The asset manager reported $1.38 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.35. KKR & Co. Inc. had a return on equity of 5.77% and a net margin of 13.21%. The company had revenue of $4.79 billion for the quarter, compared to the consensus estimate of $1.23 billion. During the same quarter in the prior year, the business posted $0.73 EPS. On average, analysts predict that KKR & Co. Inc. will post 4.12 EPS for the current year.

KKR & Co. Inc. Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, November 19th. Stockholders of record on Monday, November 4th will be given a dividend of $0.175 per share. The ex-dividend date is Monday, November 4th. This represents a $0.70 annualized dividend and a dividend yield of 0.46%. KKR & Co. Inc.’s payout ratio is currently 21.28%.

KKR & Co. Inc. Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.